SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-302333
Filing Date
2014-08-08
Accepted
2014-08-08 11:49:13
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d752657d10q.htm 10-Q 334050
2 EX-31.1 d752657dex311.htm EX-31.1 8245
3 EX-31.2 d752657dex312.htm EX-31.2 8249
4 EX-32.1 d752657dex321.htm EX-32.1 3048
5 EX-32.2 d752657dex322.htm EX-32.2 3057
  Complete submission text file 0001193125-14-302333.txt   2936935

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT clvs-20140630.xml EX-101.INS 310235
7 XBRL TAXONOMY EXTENSION SCHEMA clvs-20140630.xsd EX-101.SCH 37352
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clvs-20140630_cal.xml EX-101.CAL 47568
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clvs-20140630_def.xml EX-101.DEF 208561
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20140630_lab.xml EX-101.LAB 274610
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20140630_pre.xml EX-101.PRE 248105
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 141026321
SIC: 2834 Pharmaceutical Preparations